Cargando…

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common and lethal cancer worldwide. Radiotherapy (RT) is widely used at all stages of LUAD, and the development of immunotherapy substantially enhances the survival of LUAD patients. Although the emerging treatments for LUAD have improved prognosis, only a smal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Linzhi, Shi, Hongjie, Luo, Yuan, Sun, Wenjie, Li, Shuying, Zhang, Nannan, Jiang, Xueping, Gong, Yan, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774727/ https://www.ncbi.nlm.nih.gov/pubmed/33098370 http://dx.doi.org/10.1002/cam4.3561

Ejemplares similares

HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization
por: Sun, Wenjie, et al.
Publicado: (2021)

Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
por: Shi, Hongjie, et al.
Publicado: (2021)

Agrin Promotes Non-Small Cell Lung Cancer Progression and Stimulates Regulatory T Cells via Increasing IL-6 Secretion Through PI3K/AKT Pathway
por: Han, Linzhi, et al.
Publicado: (2022)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2021)

Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022)

SETD2 mediates immunotherapy and radiotherapy efficacy via regulating DNA damage responses and genomic stability in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
por: Li, Jiali, et al.
Publicado: (2020)

Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10
por: Yuan, Cheng, et al.
Publicado: (2021)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration
por: Xu, Jieyu, et al.
Publicado: (2020)

Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69
por: Zhou, Xuhui, et al.
Publicado: (2018)

Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors
por: Zhu, Yan, et al.
Publicado: (2023)

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

Systematic Analyses of a Chemokine Family-Based Risk Model Predicting Clinical Outcome and Immunotherapy Response in Lung Adenocarcinoma
por: Chen, Jiarui, et al.
Publicado: (2021)

Downregulated miR‐144‐3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2
por: Liu, Chao, et al.
Publicado: (2018)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Cancer‐testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma
por: Xie, Kaipeng, et al.
Publicado: (2017)

Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs
por: Fang, Weiyuan, et al.
Publicado: (2022)

PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing
por: Mao, Shuangshuang, et al.
Publicado: (2019)

SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022)

Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
por: Spella, Magda, et al.
Publicado: (2019)

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas
por: Tlemsani, Camille, et al.
Publicado: (2019)

TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
por: Guo, Longbin, et al.
Publicado: (2020)

Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma
por: Cheng, Chun-Chun, et al.
Publicado: (2020)

Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
por: Gong, Zhe, et al.
Publicado: (2020)

Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma
por: Rogerson, Connor, et al.
Publicado: (2020)

Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes
por: Zhang, Jianguo, et al.
Publicado: (2020)

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
por: Duruisseaux, Michaël, et al.
Publicado: (2016)

IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution
por: Rodriguez, Erika F., et al.
Publicado: (2020)

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
por: Hastings, Jordan F, et al.
Publicado: (2020)

Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
por: Contat, Caroline, et al.
Publicado: (2020)

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
por: Li, Yangyi, et al.
Publicado: (2022)

Aberrant CpG‐methylation affects genes expression predicting survival in lung adenocarcinoma
por: He, Wei, et al.
Publicado: (2018)

Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates
por: De Bastiani, Marco Antônio, et al.
Publicado: (2019)

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma
por: Gonzalez Rajal, Alvaro, et al.
Publicado: (2021)

An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
por: Pan, Deng, et al.
Publicado: (2020)

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
por: Xiao, Zhi-Jie, et al.
Publicado: (2017)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0e2nhc5o4rq8ct7kdo0j95ir2g